Seeking Alpha

Coppersmith Capital Management (5.8% stake) wants Alere (ALR -0.9%) to consider selling its drug...

Coppersmith Capital Management (5.8% stake) wants Alere (ALR -0.9%) to consider selling its drug testing business for ~$2.5B in order to pay down debt, according to Reuters, citing people familiar with the matter. This wouldn't be Coppersmith's first call for asset sales: the investment firm has said publicly that ALR should either sell or shutter its health management business.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector